 | • レポートコード：QY20ST-06965 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のトルブタミド市場について種類別（経口、注射）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・トルブタミド市場の概要 ・世界の主要地域別トルブタミド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のトルブタミド市場規模2015-2026：種類別（経口、注射） ・世界のトルブタミド市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・トルブタミドの北米市場規模2015-2020 ・トルブタミドのヨーロッパ市場規模2015-2020 ・トルブタミドの中国市場規模2015-2020 ・トルブタミドの日本市場規模2015-2020 ・トルブタミドの東南アジア市場規模2015-2020 ・トルブタミドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・トルブタミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・トルブタミドの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Tolbutamide (CAS 64-77-7) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Tolbutamide (CAS 64-77-7) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Tolbutamide (CAS 64-77-7), C12H18N2O3S, the formula weight is 270.35, and its form is white crystal powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Tolbutamide (CAS 64-77-7) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Tolbutamide (CAS 64-77-7) industry.
Based on our recent survey, we have several different scenarios about the Tolbutamide (CAS 64-77-7) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Tolbutamide (CAS 64-77-7) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Tolbutamide (CAS 64-77-7) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Tolbutamide (CAS 64-77-7) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Tolbutamide (CAS 64-77-7) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Tolbutamide (CAS 64-77-7) market. The report also includes nautical information, where it shows Tolbutamide (CAS 64-77-7) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Tolbutamide (CAS 64-77-7) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Tolbutamide (CAS 64-77-7) market.
Tolbutamide is suitable for the treatment of type 2 diabetes. Tolubutamide should be used in patients with high blood sugar after diet control and exercise therapy. Because of the mildening of tolbutamide, it is more suitable for mild and moderate elderly patients with diabetes.
Geographical Analysis:
Based on region, the global Tolbutamide (CAS 64-77-7) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Tolbutamide (CAS 64-77-7) market are
Pengyao Pharma
SINE
Changzhou Pharma
Changjiang Pharma
EASHU Pharma
Mylan
Sovereign
Vexxa LifeScience
Genesis Pharma
Segment by Type
Oral
Injection
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Tolbutamide (CAS 64-77-7) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Tolbutamide (CAS 64-77-7) market.
• The market share of the global Tolbutamide (CAS 64-77-7) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Tolbutamide (CAS 64-77-7) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Tolbutamide (CAS 64-77-7) market.
1 Tolbutamide (CAS 64-77-7) Market Overview
1.1 Tolbutamide (CAS 64-77-7) Product Scope
1.2 Tolbutamide (CAS 64-77-7) Segment by Type
1.2.1 Global Tolbutamide (CAS 64-77-7) Sales by Type (2020-2026)
1.2.2 Oral
1.2.3 Injection
1.3 Tolbutamide (CAS 64-77-7) Segment by Application
1.3.1 Global Tolbutamide (CAS 64-77-7) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Tolbutamide (CAS 64-77-7) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Tolbutamide (CAS 64-77-7) Sales Growth Rate (2015-2026)
1.4.2 Global Tolbutamide (CAS 64-77-7) Revenue and Growth Rate (2015-2026)
1.4.3 Global Tolbutamide (CAS 64-77-7) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Tolbutamide (CAS 64-77-7) Industry Impact
1.5.1 How the Covid-19 is Affecting the Tolbutamide (CAS 64-77-7) Industry
1.5.1.1 Tolbutamide (CAS 64-77-7) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Tolbutamide (CAS 64-77-7) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Tolbutamide (CAS 64-77-7) Players to Combat Covid-19 Impact
2 Tolbutamide (CAS 64-77-7) Estimate and Forecast by Region
2.1 Global Tolbutamide (CAS 64-77-7) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Tolbutamide (CAS 64-77-7) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Tolbutamide (CAS 64-77-7) Sales Market Share by Region (2015-2020)
2.2.2 Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Region (2015-2020)
2.3 Global Tolbutamide (CAS 64-77-7) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Tolbutamide (CAS 64-77-7) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
2.4.2 Europe Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
2.4.3 China Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
2.4.4 Japan Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
2.4.6 India Tolbutamide (CAS 64-77-7) Estimates and Projections (2015-2026)
3 Global Tolbutamide (CAS 64-77-7) Competition Landscape by Players
3.1 Global Top Tolbutamide (CAS 64-77-7) Players by Sales (2015-2020)
3.2 Global Top Tolbutamide (CAS 64-77-7) Players by Revenue (2015-2020)
3.3 Global Tolbutamide (CAS 64-77-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tolbutamide (CAS 64-77-7) as of 2019)
3.4 Global Tolbutamide (CAS 64-77-7) Average Price by Company (2015-2020)
3.5 Manufacturers Tolbutamide (CAS 64-77-7) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Tolbutamide (CAS 64-77-7) Players (Opinion Leaders)
4 Global Tolbutamide (CAS 64-77-7) Market Size by Type
4.1 Global Tolbutamide (CAS 64-77-7) Historic Market Review by Type (2015-2020)
4.1.1 Global Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
4.1.2 Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Type (2015-2020)
4.1.3 Global Tolbutamide (CAS 64-77-7) Price by Type (2014-2020)
4.2 Global Tolbutamide (CAS 64-77-7) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Tolbutamide (CAS 64-77-7) Sales Forecast by Type (2021-2026)
4.2.2 Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Type (2021-2026)
4.2.3 Global Tolbutamide (CAS 64-77-7) Price Forecast by Type (2021-2026)
5 Global Tolbutamide (CAS 64-77-7) Market Size by Application
5.1 Global Tolbutamide (CAS 64-77-7) Historic Market Review by Application (2015-2020)
5.1.1 Global Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
5.1.2 Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Application (2015-2020)
5.1.3 Global Tolbutamide (CAS 64-77-7) Price by Application (2015-2020)
5.2 Global Tolbutamide (CAS 64-77-7) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Tolbutamide (CAS 64-77-7) Sales Forecast by Application (2021-2026)
5.2.2 Global Tolbutamide (CAS 64-77-7) Revenue Forecast by Application (2021-2026)
5.2.3 Global Tolbutamide (CAS 64-77-7) Price Forecast by Application (2021-2026)
3 North America Tolbutamide (CAS 64-77-7) Market Facts & Figures
3.2 North America Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
3.3 North America Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
3.4 North America Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
4 Europe Tolbutamide (CAS 64-77-7) Market Facts & Figures
4.2 Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
4.3 Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
4.4 Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
5 China Tolbutamide (CAS 64-77-7) Market Facts & Figures
5.2 China Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
5.3 China Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
5.4 China Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
6 Japan Tolbutamide (CAS 64-77-7) Market Facts & Figures
6.2 Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
6.3 Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
6.4 Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
7 Southeast Asia Tolbutamide (CAS 64-77-7) Market Facts & Figures
7.2 Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
8 India Tolbutamide (CAS 64-77-7) Market Facts & Figures
8.2 India Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
8.3 India Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
8.4 India Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Tolbutamide (CAS 64-77-7) Business
12.1 Pengyao Pharma
12.1.1 Pengyao Pharma Tolbutamide (CAS 64-77-7) Corporation Information
12.1.2 Pengyao Pharma Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.1.3 Pengyao Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pengyao Pharma Tolbutamide (CAS 64-77-7) Products Offered
12.1.5 Pengyao Pharma Recent Development
12.2 SINE
12.2.1 SINE Tolbutamide (CAS 64-77-7) Corporation Information
12.2.2 SINE Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.2.3 SINE Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 SINE Tolbutamide (CAS 64-77-7) Products Offered
12.2.5 SINE Recent Development
12.3 Changzhou Pharma
12.3.1 Changzhou Pharma Tolbutamide (CAS 64-77-7) Corporation Information
12.3.2 Changzhou Pharma Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.3.3 Changzhou Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Changzhou Pharma Tolbutamide (CAS 64-77-7) Products Offered
12.3.5 Changzhou Pharma Recent Development
12.4 Changjiang Pharma
12.4.1 Changjiang Pharma Tolbutamide (CAS 64-77-7) Corporation Information
12.4.2 Changjiang Pharma Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.4.3 Changjiang Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Changjiang Pharma Tolbutamide (CAS 64-77-7) Products Offered
12.4.5 Changjiang Pharma Recent Development
12.5 EASHU Pharma
12.5.1 EASHU Pharma Tolbutamide (CAS 64-77-7) Corporation Information
12.5.2 EASHU Pharma Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.5.3 EASHU Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 EASHU Pharma Tolbutamide (CAS 64-77-7) Products Offered
12.5.5 EASHU Pharma Recent Development
12.6 Mylan
12.6.1 Mylan Tolbutamide (CAS 64-77-7) Corporation Information
12.6.2 Mylan Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.6.3 Mylan Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Tolbutamide (CAS 64-77-7) Products Offered
12.6.5 Mylan Recent Development
12.7 Sovereign
12.7.1 Sovereign Tolbutamide (CAS 64-77-7) Corporation Information
12.7.2 Sovereign Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.7.3 Sovereign Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sovereign Tolbutamide (CAS 64-77-7) Products Offered
12.7.5 Sovereign Recent Development
12.8 Vexxa LifeScience
12.8.1 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Corporation Information
12.8.2 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.8.3 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Vexxa LifeScience Tolbutamide (CAS 64-77-7) Products Offered
12.8.5 Vexxa LifeScience Recent Development
12.9 Genesis Pharma
12.9.1 Genesis Pharma Tolbutamide (CAS 64-77-7) Corporation Information
12.9.2 Genesis Pharma Tolbutamide (CAS 64-77-7) Business Overview and Total Revenue
12.9.3 Genesis Pharma Tolbutamide (CAS 64-77-7) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Genesis Pharma Tolbutamide (CAS 64-77-7) Products Offered
12.9.5 Genesis Pharma Recent Development
13 Tolbutamide (CAS 64-77-7) Manufacturing Cost Analysis
13.1 Tolbutamide (CAS 64-77-7) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tolbutamide (CAS 64-77-7)
13.4 Tolbutamide (CAS 64-77-7) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tolbutamide (CAS 64-77-7) Distributors List
14.3 Tolbutamide (CAS 64-77-7) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tolbutamide (CAS 64-77-7) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Tolbutamide (CAS 64-77-7) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Tolbutamide (CAS 64-77-7) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Tolbutamide (CAS 64-77-7) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Tolbutamide (CAS 64-77-7) Players to Combat Covid-19 Impact
Table 8. Global Market Tolbutamide (CAS 64-77-7) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Tolbutamide (CAS 64-77-7) Sales (Kg) by Region (2015-2020)
Table 10. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Region (2015-2020)
Table 11. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Tolbutamide (CAS 64-77-7) Revenue Share by Region (2015-2020)
Table 13. Global Tolbutamide (CAS 64-77-7) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Tolbutamide (CAS 64-77-7) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Tolbutamide (CAS 64-77-7) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Tolbutamide (CAS 64-77-7) (Kg) of Key Companies (2015-2020)
Table 18. Global Tolbutamide (CAS 64-77-7) Sales Share by Company (2015-2020)
Table 19. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Tolbutamide (CAS 64-77-7) Revenue Share by Company (2015-2020)
Table 21. Global Tolbutamide (CAS 64-77-7) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tolbutamide (CAS 64-77-7) as of 2019)
Table 22. Global Tolbutamide (CAS 64-77-7) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Tolbutamide (CAS 64-77-7) Manufacturing Sites and Area Served
Table 24. Manufacturers Tolbutamide (CAS 64-77-7) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Tolbutamide (CAS 64-77-7) Players
Table 27. Global Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 28. Global Tolbutamide (CAS 64-77-7) Sales Share by Type (2015-2020)
Table 29. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Tolbutamide (CAS 64-77-7) Price (Kg) by Type (2015-2020)
Table 31. Global Tolbutamide (CAS 64-77-7) Sales Share by Type (2021-2026)
Table 32. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Tolbutamide (CAS 64-77-7) Revenue Share by Type (2021-2026)
Table 34. Global Tolbutamide (CAS 64-77-7) Price (Kg) by Type (2021-2026)
Table 35. Global Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 36. Global Tolbutamide (CAS 64-77-7) Sales Share by Application (2015-2020)
Table 37. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Tolbutamide (CAS 64-77-7) Price (Kg) by Application (2015-2020)
Table 39. Global Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2021-2026)
Table 40. Global Tolbutamide (CAS 64-77-7) Sales Share by Application (2021-2026)
Table 41. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Tolbutamide (CAS 64-77-7) Revenue Share by Application (2021-2026)
Table 43. Global Tolbutamide (CAS 64-77-7) Price (Kg) by Application (2021-2026)
Table 44. United States Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 45. United States Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 46. United States Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 47. United States Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 48. United States Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 49. United States Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
Table 50. Europe Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 51. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 52. Europe Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 53. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 54. Europe Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 55. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 56. China Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 57. China Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 58. China Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 59. China Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 60. China Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 61. China Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
Table 62. Japan Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 63. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 64. Japan Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 65. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 66. Japan Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 67. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
Table 74. India Tolbutamide (CAS 64-77-7) Sales (Kg) by Company (2015-2020)
Table 75. India Tolbutamide (CAS 64-77-7) Sales Market Share by Company (2015-2020)
Table 76. India Tolbutamide (CAS 64-77-7) Sales (Kg) by Type (2015-2020)
Table 77. India Tolbutamide (CAS 64-77-7) Sales Market Share by Type (2015-2020)
Table 78. India Tolbutamide (CAS 64-77-7) Sales (Kg) by Application (2015-2020)
Table 79. India Tolbutamide (CAS 64-77-7) Sales Market Share by Application (2015-2020)
Table 80. Pengyao Pharma Corporation Information
Table 81. Pengyao Pharma Description and Business Overview
Table 82. Pengyao Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Pengyao Pharma Tolbutamide (CAS 64-77-7) Product
Table 84. Pengyao Pharma Recent Development
Table 85. SINE Corporation Information
Table 86. SINE Description and Business Overview
Table 87. SINE Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. SINE Tolbutamide (CAS 64-77-7) Product
Table 89. SINE Recent Development
Table 90. Changzhou Pharma Corporation Information
Table 91. Changzhou Pharma Description and Business Overview
Table 92. Changzhou Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Changzhou Pharma Tolbutamide (CAS 64-77-7) Product
Table 94. Changzhou Pharma Recent Development
Table 95. Changjiang Pharma Corporation Information
Table 96. Changjiang Pharma Description and Business Overview
Table 97. Changjiang Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Changjiang Pharma Tolbutamide (CAS 64-77-7) Product
Table 99. Changjiang Pharma Recent Development
Table 100. EASHU Pharma Corporation Information
Table 101. EASHU Pharma Description and Business Overview
Table 102. EASHU Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. EASHU Pharma Tolbutamide (CAS 64-77-7) Product
Table 104. EASHU Pharma Recent Development
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Mylan Tolbutamide (CAS 64-77-7) Product
Table 109. Mylan Recent Development
Table 110. Sovereign Corporation Information
Table 111. Sovereign Description and Business Overview
Table 112. Sovereign Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Sovereign Tolbutamide (CAS 64-77-7) Product
Table 114. Sovereign Recent Development
Table 115. Vexxa LifeScience Corporation Information
Table 116. Vexxa LifeScience Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Vexxa LifeScience Description and Business Overview
Table 118. Vexxa LifeScience Tolbutamide (CAS 64-77-7) Product
Table 119. Vexxa LifeScience Recent Development
Table . Genesis Pharma Corporation Information
Table . Genesis Pharma Tolbutamide (CAS 64-77-7) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Genesis Pharma Description and Business Overview
Table . Genesis Pharma Tolbutamide (CAS 64-77-7) Product
Table . Genesis Pharma Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. Tolbutamide (CAS 64-77-7) Distributors List
Table 128. Tolbutamide (CAS 64-77-7) Customers List
Table 129. Market Key Trends
Table 130. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 131. Key Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Tolbutamide (CAS 64-77-7) Product Picture
Figure 2. Global Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tolbutamide (CAS 64-77-7) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Tolbutamide (CAS 64-77-7) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Tolbutamide (CAS 64-77-7) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Tolbutamide (CAS 64-77-7) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Tolbutamide (CAS 64-77-7) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Tolbutamide (CAS 64-77-7) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Tolbutamide (CAS 64-77-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Tolbutamide (CAS 64-77-7) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Tolbutamide (CAS 64-77-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Tolbutamide (CAS 64-77-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Tolbutamide (CAS 64-77-7) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Tolbutamide (CAS 64-77-7) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Tolbutamide (CAS 64-77-7) Players Market Share by Revenue in Tolbutamide (CAS 64-77-7) 2015 & 2019
Figure 27. Tolbutamide (CAS 64-77-7) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Tolbutamide (CAS 64-77-7) Revenue Share by Type (2015-2020)
Figure 29. Global Tolbutamide (CAS 64-77-7) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Tolbutamide (CAS 64-77-7) Revenue Share by Application (2015-2020)
Figure 31. Global Tolbutamide (CAS 64-77-7) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 33. United States Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 34. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Company in 2019
Figure 35. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 36. Europe Tolbutamide (CAS 64-77-7) Sales Market Share by Application in 2019
Figure 37. China Tolbutamide (CAS 64-77-7) Sales Market Share by Company in 2019
Figure 38. China Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 39. China Tolbutamide (CAS 64-77-7) Sales Market Share by Application in 2019
Figure 40. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Company in 2019
Figure 41. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 42. Japan Tolbutamide (CAS 64-77-7) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Tolbutamide (CAS 64-77-7) Sales Market Share by Application in 2019
Figure 46. India Tolbutamide (CAS 64-77-7) Sales Market Share by Company in 2019
Figure 47. India Tolbutamide (CAS 64-77-7) Sales Market Share by Type in 2019
Figure 48. India Tolbutamide (CAS 64-77-7) Sales Market Share by Application in 2019
Figure 49. Pengyao Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. SINE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Changzhou Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Changjiang Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. EASHU Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sovereign Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Vexxa LifeScience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Genesis Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Tolbutamide (CAS 64-77-7)
Figure 60. Manufacturing Process Analysis of Tolbutamide (CAS 64-77-7)
Figure 61. Tolbutamide (CAS 64-77-7) Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
トルブタミドの世界市場レポート2020 A recently published report by QY Research titled Global Tolbutamide (CAS 64-77-7) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides a…- マンニトール注射の世界市場レポート2020 A recently published report by QY Research titled Global Mannitol Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…
- 経口OTC鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Oral OTC Analgesics Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease…
- パパベリン塩酸塩注射の世界市場レポート2020 A recently published report by QY Research titled Global Papaverine Hydrochloride Injection Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically p…
- スーパージェネリックの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Super Generics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Super Generics market report p…